PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3057546-1	1988	The influence of polyclonal and monoclonal antibodies, trypsin digestion and mercaptoethanol treatment of C-reactive protein (CRP) in the CRP binding to solid-phase phosphorylethanolamine (PE) has been investigated.	Mercaptoethanol	77-92	C-reactive protein	Homo sapiens	106-124	
3057546-1	1988	The influence of polyclonal and monoclonal antibodies, trypsin digestion and mercaptoethanol treatment of C-reactive protein (CRP) in the CRP binding to solid-phase phosphorylethanolamine (PE) has been investigated.	Mercaptoethanol	77-92	C-reactive protein	Homo sapiens	126-129	
3057546-1	1988	The influence of polyclonal and monoclonal antibodies, trypsin digestion and mercaptoethanol treatment of C-reactive protein (CRP) in the CRP binding to solid-phase phosphorylethanolamine (PE) has been investigated.	Mercaptoethanol	77-92	C-reactive protein	Homo sapiens	138-141	
3057546-4	1988	On the other hand, binding of CRP to PE was abolished by mercaptoethanol treatment.	Mercaptoethanol	57-72	C-reactive protein	Homo sapiens	30-33	
7401063-5	1980	Therefore, the clinical relevance of CRP detected in RF positive sera by latex agglutination can be ascertained only following pretreatment of sera with 2-mercaptoethanol or by the use of radial immunodiffusion to circumvent interference by RF.	Mercaptoethanol	153-170	C-reactive protein	Homo sapiens	37-40